jective involvement of the nervous system resulting in sensory disturbance occurred in a small proportion of diabetics (Murphy and Moxon, 1931; Joslin and Root, 1939; Buschmann et al., 1958; Michon et al., 1961) . More recently, others who considered the same problem claim that disturbances of sensation are pervasive (Collens et al., 1959; Mulder et al., 1961; Chochinov et al., 1972) . The longitudinal course and consequences of sensory deficits are also unclear, but even minimal cutaneous sensory disorders in the diabetic may produce serious disability. Sensation-defective skin in the fingertips, for example, has been shown to hinder the diabetic blind in learning Braille (Heinrichs and Moorhouse, 1969) . The common reason cited for cutaneous sensory defects is diabetic neuropathy, a heterogeneous condition (Collens et al., 1946; Heinrichs and Moorhouse, 1969; Chochinov et al., 1972) , the prevalence and causes of which are matters of current investigation (Raff and Asbury, 1968; Gabbay, 1973; Winegrad and Greene, 1976) . The state of understanding concerning neuropathy and sensory disturbances in diabetics has been summarised by Bruyn and Garland (1968) : "The prevalence may vary between zero and one hundred per cent.... The subject is Address for reprint requests: Dr J. P. Conomy Barnes (1975, 1976) . The method is analogous to the von Bekesy technique of audiometry. The patient signals sensation by pressing a lever in response to perception of non-noxious, incremental, electrical stimulation of the skin. Pressing the bar reduces the stimulus until it is no longer perceived. The testing paradigm is nonverbal, free from bias, and quantified in terms of precise characteristics of both the stimulus and the response. Although the exact identity of the receptive structures which are activated by this stimulus is unknown, since normal thresholds are uniformly low (1-3 mA), they must be restricted to the group of low threshold cutaneous receptors. The methodology has been used by our group in the study of cutaneous sensation in normal adults and children as well as in patients with a wide variety of peripheral and central nervous system diseases and chronic pain syndromes (Conomy and Barnes, 1976; Conomy et al., 1977; Cruse et al., 1977) .
During the test a stimulator operated by the subject provides pulsed constant current stimulation of the skin through 9 mm silver disc electrodes (Grass Corporation) spaced approximately 20 mm apart. A permanent computergenerated record of stimulus and nonverbal response is produced and subjected to statistical analysis ( Figure) . This analysis includes determination of mean sensory threshold, limits of stimulus intensity during detection, perceptual duration, cycle rate, and perceptual persistence indices. Skin resistance is constantly monitored. Each individual serves as his or her own control. Test sites in this study included the shoulder (C5 dermatome), the forearm (TI dermatome), the C6 dermatome in the hand, and points in the L3. L5, and S2 dermatomes in the legs and feet. Each stimulus was a 200 millisecond train of rectangular pulses at 20 Hz and 200 microseconds pulse duration. Trains were repeated once per second, with increments of 0.1 milliamperes every two seconds. For a minimum of two minutes at each site, the patient signalled perception intermittently by pressing a lever.
Fifty diabetic patients were chosen for this study and taken sequentially from volunteers in the diabetes outpatient department and the hospital wards of The Cleveland Clinic Foundation. Test subjects included 23 males and 27 Stimulus intensity increases 0.1 mA every two seconds until subject responds by pressing a lever which reduces stimulus intensity. Statistical analysis includes Ymax, current peaks at which subject first responds to indicate perception (arrows above trace); Ymin, current troughs at which response and perception cease (arrows below trace); PD, the average length in seconds of each detection response (time between vertical lines); and Ybar, the average current presented during a sample of detection behaviour.
females, ranging in age from 10 to 80 years (mean 55 years). Those with known or probable illnesses of the brain or spinal cord were excluded. Duration of diabetes ranged from newly detected to over four decades, and all forms of therapy (insulin, oral hypoglycaemic drugs, diet, and combinations of these) were used among the test group. We subdivided the diabetic patients into two groups on the basis of age of onset of the disorder. Those individuals in whom diabetes was diagnosed before the age of 31 years were classified as juvenile onset diabetics, according to the definition used by Deckert et al. (1978) and Milner (1978) .
For purposes of comparison, a nondiabetic, neurologically normal group of 20 individuals, 10 men and 10 women, ranging in age from 35 to 76 years (mean 54 years), served as control subjects. We initially subdivided the control subjects into a young group (age less than 50 years, n = 8) and an older group (age 50 years and over, n= 12) to see whether different norms should be used for patients in these two age groups. However, no significant differences (t test, P<0.05) were found between the means of the two groups for any of our test parameters. Thus the analysis of the diabetic data compares the sensory measurements for each of the diabetic patients with the 95% confidence intervals computed from the entire control group of 20 individuals.
Results and discussion
When we compared the quantitative sensory findings in the group of 50 diabetics with the 95% confidence intervals for normal control subjects, the following findings emerged. When all test sites were considered, 66% of diabetics showed elevations of the mean threshold (Table 1 , column 2). (Table 4) .
The first parameter separated 24 obese from 19 nonobese patients (Food and Nutrition Board, National Research Council, 1974) . The obese group weighed an average of 18.5+2.5 kg above their ideal weight. There was no relationship between obesity and sensory threshold at any of the three sites tested. Since obesity was not associated with the degree of threshold elevation, body weight could not predict severity of sensory alteration in diabetics. The second index we evaluated was presence or absence of retinopathy. Twenty patients had some evidence of retinopathy while 23 had none. There was no significant relationship at any site in diabetics between retinal damage and skin sensation thresholds. Thus presence of retinal damage cannot be used as an index of degree of cutaneous sensory abnormality in these patients. Next we compared juvenile diabetics (insulin-dependent diabetics with onset before the age of 31 years, n=8) with adult onset patients (n=36). Only at L5 dermatome was there a significant association: adult onset diabetics were more likely to have elevated thresholds in the feet. We also evaluated age at the time of testing in relation to perceptual threshold. We divided the diabetic group into young patients (age less than 20 years), middle-aged (aged 21 to 50 years) ,and an elderly group (aged more than 51 years). Only the foot (L5) threshold was significantly elevated with increasing age. However, since the elderly (Martin, 1953; Sullivan, 1958; Colby, 1965) , our data fail to confirm these assumptions. Our clinical-perceptual correlative studies rather suggest the following: 1. Neither the age of onset of diabetes nor the age at the time of quantitative sensory testing can be used to predict the presence or absence of a cutaneous sensory abnormality. There are older diabetics who, by our methods, are found to be normal, and diabetic children who are found to be abnormal. 2. The type and duration of diabetic treatment cannot always be used as a predictor of the presence of cutaneous sensory abnormality, since defective skin sensation can be demonstrated in newly discovered diabetics as well as in those treated by diet, drugs, or insulin, alone or in combination for various periods of time. 3. Sensory abnormality appears in the slender as well as in the obese diabetic and in the face of either normal or abnormal postprandial blood glucose levels. 4. Symptomatic diabetic nephropathy, evidenced by proteinuria and hypertension with impaired renal function and present in 6% of the patients in this series, and diabetic retinopathy, detectable in 25% of the series, were similarly not correlated with the presence of a cutaneous sensory abnormality in a clear way.
